Literature DB >> 11342715

Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor.

C Heiring1, Y A Muller.   

Abstract

The production of recombinant proteins in Escherichia coli often leads to the formation of inclusion bodies. Although this has a number of advantages, a major disadvantage is the need to develop folding protocols for the renaturing of the proteins. However, the systematic screening of folding conditions is often hampered by the lack of convenient assays to detect correctly folded proteins. To address this problem we present a simple protocol, which combines folding screens and limited proteolysis to rapidly assess and optimize folding conditions. The efficacy of this method, termed FSAP (folding screening assayed by proteolysis), is demonstrated by the large-scale folding, purification and crystallization of various cystine deletion mutants of the cystine knot family member: vascular endothelial growth factor (VEGF). These mutants are particularly difficult to fold as the cystine knot is believed to make major contributions to the stability of the protein and this family of proteins lacks extensive hydrophobic core regions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342715     DOI: 10.1093/protein/14.3.183

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  8 in total

1.  Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.

Authors:  Karen M McCammon; Satya P Panda; Chuanwu Xia; Jung-Ja P Kim; Daniela Moutinho; Michel Kranendonk; Richard J Auchus; Eileen M Lafer; Debashis Ghosh; Pavel Martasek; Rekha Kar; Bettie Sue Masters; Linda J Roman
Journal:  J Biol Chem       Date:  2016-08-05       Impact factor: 5.157

2.  Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70.

Authors:  Amy K Schaefer; Hannah C Wastyk; Vishnu Mohanan; Ching-Wen Hou; Mackenzie L Lauro; James E Melnyk; Jason M Burch; Catherine L Grimes
Journal:  Biochemistry       Date:  2017-08-15       Impact factor: 3.162

3.  Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.

Authors:  Carlene S Starck; Andrew J Sutherland-Smith
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

4.  An automated in vitro protein folding screen applied to a human dynactin subunit.

Authors:  Christoph Scheich; Frank H Niesen; Robert Seckler; Konrad Büssow
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

5.  αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells.

Authors:  Qing Ruan; Song Han; Wen G Jiang; Michael E Boulton; Zhi J Chen; Brian K Law; Jun Cai
Journal:  Mol Cancer Res       Date:  2011-10-07       Impact factor: 5.852

6.  Identification of a Novel TGF-β-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-β-Receptor-3 (TGFR-3).

Authors:  Uschi Diestel; Marcus Resch; Kathrin Meinhardt; Sigrid Weiler; Tina V Hellmann; Thomas D Mueller; Joachim Nickel; Jutta Eichler; Yves A Muller
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

7.  Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.

Authors:  Ondřej Kaplan; Jana Zárubová; Barbora Mikulová; Elena Filová; Jiřina Bártová; Lucie Bačáková; Eduard Brynda
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

8.  Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.

Authors:  Elisabeth Lobner; Anne-Sophie Humm; Georg Mlynek; Konstantin Kubinger; Michael Kitzmüller; Michael W Traxlmayr; Kristina Djinović-Carugo; Christian Obinger
Journal:  MAbs       Date:  2017-08-17       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.